Immediate Impact
58 standout
Citing Papers
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
Works of Raghuveer Ramachandra being referenced
PD-1 derived CA-170 is an oral immune checkpoint inhibitor that exhibits preclinical anti-tumor efficacy
2021
A Rationally Designed Peptide Antagonist of the PD-1 Signaling Pathway as an Immunomodulatory Agent for Cancer Therapy
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Raghuveer Ramachandra | 186 | 111 | 153 | 23 | 393 | |
| Yuta Endo | 42 | 135 | 44 | 40 | 344 | |
| Takayuki Amano | 56 | 109 | 87 | 20 | 373 | |
| Muhammad Nadeem Abbas | 103 | 152 | 186 | 16 | 385 | |
| Maja Matulić | 64 | 180 | 121 | 30 | 395 | |
| Suchitra Mohanty | 109 | 191 | 161 | 16 | 438 | |
| David E. Mold | 54 | 236 | 25 | 16 | 395 | |
| Shye‐Jye Tang | 117 | 219 | 107 | 25 | 457 | |
| Е. В. Моисеева | 69 | 175 | 106 | 29 | 355 | |
| Wendy Freebern | 74 | 176 | 96 | 27 | 389 | |
| Qiming Chen | 77 | 182 | 79 | 29 | 412 |
All Works
Loading papers...